Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04148807
Other study ID # 18-11-15
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 5, 2019
Est. completion date March 30, 2023

Study information

Verified date September 2022
Source Northeastern University
Contact Joshua Stefanik, MSPT, PhD
Phone 6173738934
Email j.stefanik@northeastern.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the feasibility of a gait-retraining program for older adults with knee osteoarthritis. The study will enroll 40 participants, with 20 receiving a gait retraining intervention and 20 receiving a graded walking program without gait retraining.


Description:

Knee osteoarthritis (OA) is a chronic condition affecting ~12% of older adults in the United States and is a leading cause of disability. Knee pain is a common clinical manifestation that leads individuals with OA to seek medical care. Current rehabilitation approaches (e.g., bracing, taping, foot orthoses, strengthening, etc.) aim to reduce knee joint loading, a well-accepted risk factor for knee OA and pain, but are not always effective. Altering gait mechanics to reduce knee loading has also been suggested. Gait retraining studies for individuals with knee OA have focused on increasing trunk lean and toe out angle to reduce the knee adduction moment (a surrogate measure of joint loading). However, these strategies create an abnormal gait pattern and may not be the best long-term solutions due to the potential injury to other joints which may limit their overall effectiveness and applicability to clinical practice. Impact loading, another mechanical factor related to knee OA, has been reduced using gait retraining strategies in runners with knee pain. It is unknown if gait retraining strategies to decrease impact loading can reduce symptoms of knee OA. Thus, the purpose of this study is to determine the feasibility of a gait retraining program focusing on decreasing impact loading in individuals with knee OA. At baseline, following 8 intervention sessions, and at 1-month follow-up, participants will complete questionnaires, undergo three-dimensional gait analysis, and assessment of pressure pain threshold. Note: For participants enrolled during COVID-19 outbreak, only questionnaires will be collected at follow-up assessments.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date March 30, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility Inclusion Criteria: Subjects with a clinical definition of knee OA using NICE guidelines: - Age = 45 - Walking related joint pain in the last week that averages = 4 on 11-point numeric rating scale, where 0 = no pain and 10 = worst pain possible - History of knee pain for at least 3 months - Morning stiffness in the morning lasting less than 30 minutes Exclusion Criteria: - Walk with an assistive device - Current use of oral opiates or centrally acting pain medications - History of lower extremity surgery - Underwent an intra-articular knee joint injection in the past 3 months - Suffer from inflammatory arthritis or other conditions that affect lower extremity functions - Currently receiving treatment for their knee and unwilling to stop this treatment for the duration of the study - Currently pregnant - Skin allergies to adhesives

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Progressive Walking with Gait Retraining
A progressive walking program with gait retraining will be performed on a treadmill at self-selected comfortable walking speed wearing an inertial measurement unit (IMU) on the medial aspect of the distal tibia. The (vertical) peak positive acceleration (PPA) of the tibia is a measure of tibial shock. Subjects will be provided real-time audio feedback to reduce PPA by 20% of their average peak PPA. During retraining sessions, a faded feedback approach will be used. Feedback will be provided continuously during the first four sessions and will be faded over the last 4 sessions. Walking time will increase over the 8 sessions.
Progressive Walking Program
A progressive walking program will also be performed on a treadmill where subjects will walk at a self-selected comfortable speed with the same walking times per session as the retraining group without any feedback or retraining cues.

Locations

Country Name City State
United States Northeastern University Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Northeastern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rate # of participants screened per month through study completion, an average of 2 years
Primary Enrollment rate # of participants enrolled per month through study completion, an average of 2 years
Primary Retention % participants that complete all study visits through study completion, an average of 2 years
Secondary Withdrawals/Terminated Proportion of participants who withdraw or terminated by investigators and reasons why through study completion, an average of 2 years
Secondary Adverse events (AE)/Unanticipated problems (UP) Proportion of participants with AE/UP through study completion, an average of 2 years
Secondary Vertical average loading rate Slope of the most linear portion of the vertical ground reaction force curve, during early stance. Change from baseline to conclusion of intervention, an average of 1-month
Secondary Vertical instantaneous loading rate Maximum slope of the most vertical portion of the vertical ground reaction force curve between successive data points, during early stance. Change from baseline to conclusion of intervention, an average of 1-month
Secondary Knee Pain with Activities WOMAC questionnaire, pain sub scale 0-20 Change from baseline to conclusion of intervention, an average of 1-month
Secondary Knee Pain Severity Visual analog scale, 0-100 Change from baseline to conclusion of intervention, an average of 1-month
Secondary Pressure pain threshold Assessed using hand held algometer Change from baseline to conclusion of intervention, an average of 1-month
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Not yet recruiting NCT02865174 - Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty Phase 4
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT03037489 - A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients Phase 2